Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2022 Filed Feb 18, 2022 20:25 UTC |
Harvey Joan BDirector
|
GrantEmployee stock option (right to buy) · Derivative | 179,350 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001062993-22-004927 · form4.xml · derivative · entry 1 Harvey Joan B · CIK 0001912325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,350 Underlying: Common stock · 179,350 shares Expires 2032-02-11 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, commencing March 31, 2022. Read SEC document |
| June 15, 2021 Filed Mar 1, 2022 23:20 UTC |
Baxter Timothy EDirector
|
GrantEmployee stock option (right to buy) · Derivative | 75,000 | $0.00 Strike: $5.79 | $0.00 |
DisclosureSEC source: 0001062993-22-006202 · form4.xml · derivative · entry 1 Baxter Timothy E · CIK 0001914275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common stock · 75,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, commencing on June 30, 2021. Read SEC document |
| April 29, 2021 Filed May 3, 2021 20:14 UTC |
White DebraDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001094891-21-000188 · edgar.xml · derivative · entry 1 White Debra · CIK 0001859882 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-04-29 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, commencing on June 30, 2021. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:09 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-21-000165 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,255,913 F1 · price: Dr. Aklog was granted 150,000 shares of restricted stock pursuant to the issuer's long term incentive plan. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 23:05 UTC |
MCGRATH DENNIS MPresident & CFO
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-21-000178 · edgar.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 955,462 F1 · price: The issuer granted 150,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. F2 · balance_after: Includes an aggregate of 26,462 shares of common stock purchased pursuant to the issuer's employee stock purchase program. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 23:09 UTC |
Battleman David S.Director
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001094891-21-000180 · edgar.xml · derivative · entry 1 Battleman David S. · CIK 0001714335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-04-01 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on September 30, 2021. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:31 UTC |
Cox James LDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001094891-21-000176 · edgar.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-04-01 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on September 30, 2021. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:27 UTC |
Glennon Michael JDirector · Vice Chairman
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001094891-21-000174 · edgar.xml · derivative · entry 1 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-04-01 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on September 30, 2021. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:23 UTC |
Sparks Ronald MDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001094891-21-000172 · edgar.xml · derivative · entry 1 Sparks Ronald M · CIK 0001665394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-04-01 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on September 30, 2021. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:18 UTC |
Weild IV DavidDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001094891-21-000170 · edgar.xml · derivative · entry 1 Weild IV David · CIK 0001648023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-04-01 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on September 30, 2021. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:15 UTC |
DeGuzman Brian J.Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001094891-21-000168 · edgar.xml · derivative · entry 1 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-04-01 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on September 30, 2021. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 17:07 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 7,500 | $4.31 | $32,323.50 |
DisclosureSEC source: 0001094891-21-000143 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105,913 Read SEC document |
| November 25, 2020 Filed Nov 27, 2020 15:07 UTC |
SIROVICH MATTHEW10% owner
|
SaleCommon Stock | 33,203 | $1.96 | $65,048.00 |
DisclosureSEC source: 0000899243-20-032252 · doc4.xml · nonDerivative · entry 2 SIROVICH MATTHEW · CIK 0001431208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,027,744 F1 · ownership.nature: Securities of PAVmed Inc. (the "Issuer") held directly by the Sirovich Family Charitable Foundation (the "Sirovich Foundation"). Matthew Sirovich is a Director and President of the Sirovich Foundation and may be deemed to beneficially own the securities of the Issuer held by the Sirovich Foundation. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 15:07 UTC |
SIROVICH MATTHEW10% owner
|
SaleCommon Stock | 53,036 | $2.00 | $105,875.77 |
DisclosureSEC source: 0000899243-20-032252 · doc4.xml · nonDerivative · entry 1 SIROVICH MATTHEW · CIK 0001431208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,060,947 F1 · ownership.nature: Securities of PAVmed Inc. (the "Issuer") held directly by the Sirovich Family Charitable Foundation (the "Sirovich Foundation"). Matthew Sirovich is a Director and President of the Sirovich Foundation and may be deemed to beneficially own the securities of the Issuer held by the Sirovich Foundation. Read SEC document |
| November 19, 2020 Filed Nov 20, 2020 13:01 UTC |
SIROVICH MATTHEW10% owner
|
SaleCommon Stock | 75,211 | $1.83 | $137,418.02 |
DisclosureSEC source: 0000899243-20-031786 · doc4.xml · nonDerivative · entry 2 SIROVICH MATTHEW · CIK 0001431208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,113,983 F1 · ownership.nature: Securities of PAVmed Inc. (the "Issuer") held directly by the Sirovich Family Charitable Foundation (the "Sirovich Foundation"). Matthew Sirovich is a Director and President of the Sirovich Foundation and may be deemed to beneficially own the securities of the Issuer held by the Sirovich Foundation. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 13:01 UTC |
SIROVICH MATTHEW10% owner
|
SaleCommon Stock | 24,789 | $1.78 | $44,164.08 |
DisclosureSEC source: 0000899243-20-031786 · doc4.xml · nonDerivative · entry 1 SIROVICH MATTHEW · CIK 0001431208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,189,194 F1 · ownership.nature: Securities of PAVmed Inc. (the "Issuer") held directly by the Sirovich Family Charitable Foundation (the "Sirovich Foundation"). Matthew Sirovich is a Director and President of the Sirovich Foundation and may be deemed to beneficially own the securities of the Issuer held by the Sirovich Foundation. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 13:18 UTC |
SIROVICH MATTHEW10% owner
|
SaleCommon Stock | 131,082 | $1.98 | $259,476.82 |
DisclosureSEC source: 0001567619-20-011404 · doc1.xml · nonDerivative · entry 2 SIROVICH MATTHEW · CIK 0001431208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,213,983 F1 · ownership.nature: Securities of PAVmed Inc. (the "Issuer") held directly by the Sirovich Family Charitable Foundation (the "Sirovich Foundation"). Matthew Sirovich is a Director and President of the Sirovich Foundation and may be deemed to beneficially own the securities of the Issuer held by the Sirovich Foundation. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 13:18 UTC |
SIROVICH MATTHEW10% owner
|
SaleCommon Stock | 69,839 | $2.06 | $143,665.81 |
DisclosureSEC source: 0001567619-20-011404 · doc1.xml · nonDerivative · entry 1 SIROVICH MATTHEW · CIK 0001431208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,345,065 F1 · ownership.nature: Securities of PAVmed Inc. (the "Issuer") held directly by the Sirovich Family Charitable Foundation (the "Sirovich Foundation"). Matthew Sirovich is a Director and President of the Sirovich Foundation and may be deemed to beneficially own the securities of the Issuer held by the Sirovich Foundation. Read SEC document |
| April 30, 2020 Filed May 4, 2020 21:25 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
Pavilion Venture Partners LLC10% owner
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-20-000066 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,098,413 F1 · price: The issuer granted 250,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. Read SEC document |
| April 30, 2020 Filed May 4, 2020 21:23 UTC |
MCGRATH DENNIS MPresident & CFO
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-20-000065 · edgar.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 791,704 F1 · price: The issuer granted 250,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. Read SEC document |
| April 30, 2020 Filed May 4, 2020 22:08 UTC |
Weild IV DavidDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001094891-20-000080 · edgar.xml · derivative · entry 1 Weild IV David · CIK 0001648023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-04-30 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on June 30, 2020. Read SEC document |
| April 30, 2020 Filed May 4, 2020 22:06 UTC |
Sparks Ronald MDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001094891-20-000078 · edgar.xml · derivative · entry 1 Sparks Ronald M · CIK 0001665394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-04-30 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on June 30, 2020. Read SEC document |
| April 30, 2020 Filed May 4, 2020 22:03 UTC |
Glennon Michael JDirector · Vice Chairman
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001094891-20-000076 · edgar.xml · derivative · entry 1 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-04-30 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on June 30, 2020. Read SEC document |
| April 30, 2020 Filed May 4, 2020 22:02 UTC |
DeGuzman Brian J.Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001094891-20-000074 · edgar.xml · derivative · entry 1 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-04-30 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on June 30, 2020. Read SEC document |
| April 30, 2020 Filed May 4, 2020 21:46 UTC |
Cox James LDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001094891-20-000070 · edgar.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-04-30 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on June 30, 2020. Read SEC document |
| April 30, 2020 Filed May 4, 2020 21:45 UTC |
Battleman David S.Director
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001094891-20-000068 · edgar.xml · derivative · entry 1 Battleman David S. · CIK 0001714335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-04-30 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on June 30, 2020. Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 16:05 UTC |
SIROVICH MATTHEW10% owner
|
OtherSeries S Warrants (right to buy) · Derivative | 1,199,383 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001567619-20-001925 · doc1.xml · derivative · entry 4 SIROVICH MATTHEW · CIK 0001431208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,199,383 shares Expires 2032-06-30 F1 · kind: Securities of PAVmed Inc. (the "Issuer") acquired as a result of the exercise of Series S Warrants of the Issuer. F2 · derivative.exercise_date: The Series S Warrants were subject to a limitation on exercise such that they could not be exercised if following such exercise Mr. Sirovich would beneficially own greater than 4.75% of the outstanding shares of the Issuer's common stock. Such limitation on exercise was lifted on January 23, 2019. Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 16:05 UTC |
SIROVICH MATTHEW10% owner
|
OtherCommon Stock | 1,199,383 | $0.01 | $11,993.83 |
DisclosureSEC source: 0001567619-20-001925 · doc1.xml · nonDerivative · entry 1 SIROVICH MATTHEW · CIK 0001431208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,938,297 F1 · kind: Securities of PAVmed Inc. (the "Issuer") acquired as a result of the exercise of Series S Warrants of the Issuer. Read SEC document |
| May 24, 2019 Filed May 28, 2019 20:06 UTC |
MCGRATH DENNIS MPresident & CFO
|
PurchaseCommon Stock | 5,000 | $1.09 | $5,428.50 |
DisclosureSEC source: 0001094891-19-000123 · edgar.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 529,000 Read SEC document |
| May 23, 2019 Filed May 28, 2019 20:03 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 30,000 | $1.10 | $32,850.00 |
DisclosureSEC source: 0001094891-19-000121 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 848,413 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from 1.07 to $1.11 per share, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:18 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
Pavilion Venture Partners LLC10% owner
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-19-000093 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818,413 F1 · price: The issuer granted 200,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:10 UTC |
MCGRATH DENNIS MEVP & CFO
|
GrantCommon Stock | 500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-19-000092 · edgar.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 524,000 F1 · price: The issuer granted 500,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 01:23 UTC |
Glennon Michael JDirector · Vice Chairman
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001094891-19-000087 · edgar.xml · derivative · entry 1 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-03-07 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on March 31, 2019. Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 01:21 UTC |
Sparks Ronald MDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001094891-19-000086 · edgar.xml · derivative · entry 1 Sparks Ronald M · CIK 0001665394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-03-07 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on March 31, 2019. Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 01:19 UTC |
DeGuzman Brian J.Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001094891-19-000085 · edgar.xml · derivative · entry 1 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-03-07 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on March 31, 2019. Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 01:17 UTC |
Weild IV DavidDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001094891-19-000084 · edgar.xml · derivative · entry 1 Weild IV David · CIK 0001648023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-03-07 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on March 31, 2019. Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 11:59 UTC |
Battleman David S.Director
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001094891-19-000088 · edgar.xml · derivative · entry 1 Battleman David S. · CIK 0001714335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-03-07 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on March 31, 2019. Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 12:01 UTC |
Cox James LDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001094891-19-000089 · edgar.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-03-07 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on March 31, 2019. Read SEC document |
| December 27, 2018 Filed Jan 28, 2019 13:23 UTC |
SIROVICH MATTHEW10% owner
|
OtherCommon Stock | 60,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-19-001732 · doc1.xml · nonDerivative · entry 2 SIROVICH MATTHEW · CIK 0001431208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 792,000 F1 · kind: Securities of PAVMed Inc. (the "Issuer") acquired in settlement of all remaining accrued and unpaid interest outstanding under the Issuer's 15% Senior Secured Note due 2019 in connection with the repayment of such note. F1 · price: Securities of PAVMed Inc. (the "Issuer") acquired in settlement of all remaining accrued and unpaid interest outstanding under the Issuer's 15% Senior Secured Note due 2019 in connection with the repayment of such note. F2 · ownership.nature: Securities of the Issuer held directly by The Boomer Fund, L.P. ("Boomer"). Mr. Sirovich is the general partner of Boomer and may be deemed to beneficially own the securities of the Issuer held by Boomer. Read SEC document |
| December 27, 2018 Filed Jan 28, 2019 13:23 UTC |
SIROVICH MATTHEW10% owner
|
OtherCommon Stock | 272,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-19-001732 · doc1.xml · nonDerivative · entry 1 SIROVICH MATTHEW · CIK 0001431208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 738,914 F1 · kind: Securities of PAVMed Inc. (the "Issuer") acquired in settlement of all remaining accrued and unpaid interest outstanding under the Issuer's 15% Senior Secured Note due 2019 in connection with the repayment of such note. F1 · price: Securities of PAVMed Inc. (the "Issuer") acquired in settlement of all remaining accrued and unpaid interest outstanding under the Issuer's 15% Senior Secured Note due 2019 in connection with the repayment of such note. Read SEC document |
| August 28, 2018 Filed Aug 28, 2018 21:27 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 30,000 | $1.18 | $35,400.00 |
DisclosureSEC source: 0001094891-18-000164 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618,413 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.17 to $1.20 per share, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 26, 2018 Filed Jul 11, 2018 21:42 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
Pavilion Venture Partners LLC10% owner
|
OtherSeries Z Warrants · Derivative | 968,019 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001094891-18-000152 · edgar.xml · derivative · entry 11 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pavilion Venture Partners LLC Disclosed balance after: 2,078,285 Underlying: Common Stock · 2,078,285 shares Expires 2024-04-30 F5 · price: The Series Z Warrants were contributed to such entity by its members for no consideration. The contributed Series Z Warrants include 322,673 Series Z Warrants that were previously held indirectly by Dr. Aklog through HCFP/Capital Partners III LLC and became held directly by Dr. Aklog on June 26, 2016. F2 · ownership.nature: Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| June 26, 2018 Filed Jul 11, 2018 21:49 UTC |
Glennon Michael JDirector · Vice Chairman
|
OtherSeries Z Warrants · Derivative | 322,673 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001094891-18-000154 · edgar.xml · derivative · entry 2 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 0 Underlying: Common Stock · 322,673 shares Expires 2024-04-30 F2 · kind: Contribution to Pavilion Venture Partners LLC, of which the trust is a non-managing member. Read SEC document |
| June 26, 2018 Filed Jul 11, 2018 21:49 UTC |
Glennon Michael JDirector · Vice Chairman
|
OtherSeries Z Warrants · Derivative | 322,673 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001094891-18-000154 · edgar.xml · derivative · entry 1 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 322,673 Underlying: Common Stock · 322,673 shares Expires 2024-04-30 F1 · kind: Pro rata distribution from HCFP/Capital Partners III LLC, of which the trust is a non-managing member. Read SEC document |
| June 26, 2018 Filed Jul 12, 2018 19:49 UTC |
DeGuzman Brian J.Chief Medical Officer
|
OtherSeries Z Warrants · Derivative | 322,673 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001094891-18-000156 · edgar.xml · derivative · entry 2 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 0 Underlying: Common Stock · 322,673 shares Expires 2024-04-30 F2 · kind: Contribution to Pavilion Venture Partners LLC, of which the trust is a non-managing member. Read SEC document |
| June 26, 2018 Filed Jul 12, 2018 19:49 UTC |
DeGuzman Brian J.Chief Medical Officer
|
OtherSeries Z Warrants · Derivative | 322,673 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001094891-18-000156 · edgar.xml · derivative · entry 1 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 322,673 Underlying: Common Stock · 322,673 shares Expires 2024-04-30 F1 · kind: Pro rata distribution from HCFP/Capital Partners III LLC, of which the trust is a non-managing member. Read SEC document |
| June 12, 2018 Filed Jul 11, 2018 21:42 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
Pavilion Venture Partners LLC10% owner
|
OtherSeries Z Warrants · Derivative | 980 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001094891-18-000152 · edgar.xml · derivative · entry 10 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 980 Underlying: Common Stock · 980 shares Expires 2024-04-30 F1 · price: The reporting person purchased units from the issuer in the issuer's equity rights offering, each unit consisting of one share of the issuer's common stock and one Series Z Warrant, at a price of $1.15 per unit. Read SEC document |
| June 12, 2018 Filed Jul 11, 2018 21:42 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
Pavilion Venture Partners LLC10% owner
|
OtherSubscription Rights (Right to Buy) · Derivative | 980 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001094891-18-000152 · edgar.xml · derivative · entry 9 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 0 Underlying: Units (1 share of Common Stock and 1 Series Z Warrant) · 980 shares Expires 2018-06-12 Read SEC document |
| June 12, 2018 Filed Jul 11, 2018 21:42 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
Pavilion Venture Partners LLC10% owner
|
OtherSeries Z Warrants · Derivative | 1,018 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001094891-18-000152 · edgar.xml · derivative · entry 8 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 1,018 Underlying: Common Stock · 1,018 shares Expires 2024-04-30 F1 · price: The reporting person purchased units from the issuer in the issuer's equity rights offering, each unit consisting of one share of the issuer's common stock and one Series Z Warrant, at a price of $1.15 per unit. Read SEC document |
| June 12, 2018 Filed Jul 11, 2018 21:42 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
Pavilion Venture Partners LLC10% owner
|
OtherSubscription Rights (Right to Buy) · Derivative | 1,018 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001094891-18-000152 · edgar.xml · derivative · entry 7 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 0 Underlying: Units (1 share of Common Stock and 1 Series Z Warrant) · 1,018 shares Expires 2018-06-12 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.